PE/Cyanine7 anti-mouse Ly-6G Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Ly-6G transfected EL-4J cell line.

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser

Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)

Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C¹⁵. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A8¹⁵. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.4¹⁶.

Additional reported applications (for the relevant formats) include: immunohistochemistry⁹ of frozen sections¹⁰ and paraffin-embedded sections¹¹, depletion^{4, 12-14}, and spatial biology (IBEX)^20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Additional Product Notes

BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.

Application References

(PubMed link indicates BioLegend citation)

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
2. Bernasconi R, et al. 2021. EMBO Mol Med. :e14392. PubMed
3. Furuya Y, et al. 2014. J Virol. 88:9166. PubMed
4. Dudek M, et al. 2015. Mucosal Immunol. . PubMed
5. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
6. Laura C Burzynski et al. 2019. Immunity. 50(4):1033-1042 . PubMed
7. Gawish R, et al. 2022. Elife. 11:. PubMed
8. Israelow B, et al. 2020. bioRxiv. . PubMed
9. Bieren J, et al. 2015. J Immunol. 194:1154. PubMed
10. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
11. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
12. Hu W, et al. 2021. Nat Immunol. 22:1163. PubMed
13. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
14. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
15. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
16. Buxadé M, et al. 2018. J Exp Med. 215:2901. PubMed
17. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
18. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
19. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
20. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
21. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
22. Douglas T, et al. 2015. J Immunol. 195: 2365-2373. PubMed
23. Mercer HL, et al. 2020. PLoS Pathog. 16:e1008572. PubMed
24. Katsura A, et al. 2017. Mol Oncol. 11:1241. PubMed
25. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
26. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
27. Gómez-Díaz C, et al. 2021. iScience. 24:103241. PubMed
28. Boothby IC, et al. 2021. Nature. 599:667. PubMed
29. Sanfilippo A, et al. 2015. Infect Immun . 83: 2976-2983. PubMed
30. Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
31. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
32. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
33. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
34. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
35. Liao Y, et al. 2017. Virol J. 10.1186/s12985-017-0801-x. PubMed
36. Swidergall M, et al. 2019. Cell Rep. 28:423. PubMed
37. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
38. Sitnik S, et al. 2020. Mol Ther Oncolytics. 17:190. PubMed
39. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
40. Lu S, et al. 2020. JCI Insight. 5:00. PubMed
41. Philip N, et al. 2016. PLoS Pathog. 12:e1005910. PubMed
42. Park Y, et al. 2013. Cancer Res . 73:5669. PubMed
43. Campana L, et al. 2018. J Immunol. 200:1169. PubMed
44. Pan W et al. 2017. Immunity. 47(2):284-297 . PubMed
45. Donlan AN, et al. 2020. Anaerobe. 66:102275. PubMed
46. Yu X, et al. 2022. J Extracell Vesicles. 11:e12185. PubMed
47. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
48. Zhou Y, et al. 2022. Nat Commun. 13:2906. PubMed
49. Gabbita S, et al. 2015. PLoS One. 10: e0137305. PubMed
50. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
51. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
52. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
53. Ngamsri KC, et al. 2021. Int J Mol Sci. 22:. PubMed
54. Guo L, et al. 2021. Front Immunol. 12:785457. PubMed
55. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
56. Singh S, et al. 2021. Cell Host Microbe. 29(3):347-361.e12. PubMed
57. Yin S, et al. 2016. Nat Commun. 7: 11311. PubMed
58. Chan C, et al. 2012. Hypertension. 60:1207. PubMed
59. Domingos-Pereira S, et al. 2019. Cancer Immunol Res. 7:621. PubMed
60. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
61. Grune J, et al. 2022. Nat Cardiovasc Res. 1:649. PubMed
62. Guo P, et al. 2021. J Immunol. 207:408. PubMed
63. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
64. Furuya Y, et al. 2015. PLoS Pathog. 11: 1005180. PubMed
65. Lasso P, et al. 2020. Front Immunol. 584959:11. PubMed
66. Sun KT, et al. 2018. Front Physiol. 1.06875. PubMed
67. Shook BA, et al. 2020. Cell Stem Cell. 26(6):880-895. PubMed
68. , et al. 2021. Eur J Immunol. 51:2708. PubMed
69. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
70. Nguyen GT, et al. 2021. iScience. 24(8):102871. PubMed
71. AM C, et al. 2015. Proc Natl Acad Sci U S A. 112 7557 . PubMed
72. Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
73. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
74. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
75. Yang Y, et al. 2022. Elife. 11:. PubMed
76. Germundson DL, et al. 2022. Front Allergy. 3:870513. PubMed
77. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
78. Soni C, et al. 2020. Immunity. 52(6):1022-1038.e7. PubMed
79. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
80. Kaufmann E et al. 2018. Cell. 172(1-2):176-190 . PubMed
81. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
82. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
83. Otvos B, et al. 2021. Clin Cancer Res. 27:2038. PubMed
84. Poczobutt JM, et al. 2021. Am J Respir Cell Mol Biol. 64:629. PubMed
85. Ding P, et al. 2022. Bone Res. 10:42. PubMed
86. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
87. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
88. Bryant J, et al. 2014. J Immunol. 192:6092. PubMed
89. Fischer KJ, et al. 2019. J Immunol. 202:2027. PubMed
90. Nair S, et al. 2021. JCI Insight. 6:. PubMed
91. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
92. Lingegowda H, et al. 2022. Front Reprod Health. 3:726936. PubMed
93. Almishri W, et al. 2015. J Hepatol. 63: 943-951. PubMed
94. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
95. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
96. Moore J, et al. 2015. Am J Physiol Heart Circ Physiol. 309: 906-917. PubMed
97. Johansson J, et al. 2013. J Neurosci. 33:16016. PubMed
98. Jordan S, et al. 2020. Cell. 178(5):1102-1114.e17.. PubMed
99. Ngamsri KC, et al. 2020. Front Immunol. 11:407. PubMed
100. Wong NR, et al. 2021. Immunity. 54:2072. PubMed
101. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
102. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
103. Alexander K, et al. 2016. Immunol Cell Biol. 95:7-16. PubMed
104. Kwak T, et al. 2020. Cell Reports. 33(13):108571. PubMed
105. Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
106. Chhatbar C et al. 2018. Cell reports. 25(1):118-129 . PubMed
107. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
108. Wang X, et al. 2021. Cell. 184:5357. PubMed
109. Xiao Y, et al. 2021. Cell. 184:6037. PubMed
110. Casselli T, et al. 2021. PLoS Pathog. 17:e1009256. PubMed
111. Israelow B, et al. 2020. J Exp Med. 217:00:00. PubMed
112. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
113. Tang W, et al. 2021. Front Cell Dev Biol. 9:728057. PubMed
114. Tang S, et al. 2022. Virol J. 19:32. PubMed
115. Smith KJ, et al. 2022. PLoS Biol. 20:e3001554. PubMed
116. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
117. Nguyen GT, et al. 2020. eLife. 9:e56656.. PubMed
118. Chavkin NW, et al. 2021. J Am Heart Assoc. 10:e019904. PubMed
119. Wang X, et al. 2021. Theranostics. 11:209. PubMed
120. Kwok I, et al. 2020. Immunity. 53(2):303-318.e5. PubMed
121. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
122. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
123. Mogilenko DA et al. 2019. Cell. 177(5):1201-1216 . PubMed
124. Braza MS et al. 2018. Immunity. 49(5):819-828 . PubMed
125. White JP et al. 2018. Cell. 175(5):1198-1212 . PubMed
126. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
127. Dietschmann A, et al. 2020. Eur J Immunol. 50:1044. PubMed
128. Lee J, et al. 2015. Nat Commun. 6: 8499. PubMed
129. Goc J, et al. 2021. Cell. 184:5015. PubMed
130. Das A, et al. 2020. J Bone Miner Res. 36:199. PubMed
131. Thurlow LR, et al. 2018. Cell Host Microbe. 24:261. PubMed
132. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
133. Zhou J, et al. 2019. Cell Stem Cell. 24:285. PubMed
134. Wu L, et al. 2021. Cell Death Dis. 12:1064. PubMed
135. Chirivi RGS, et al. 2020. Cell Mol Immunol. . PubMed
136. Denk F, et al. 2016. Cell Rep. 15: 1771-1781. PubMed

RRID

AB_1877262 (BioLegend Cat. No. 127617)
AB_1877261 (BioLegend Cat. No. 127618)

Antigen Details

Structure

A 21-35 kD GPI-anchorded membrane protein

Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type

Granulocytes, Macrophages, Monocytes

Biology Area

Immunology, Innate Immunity

Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID

546644 View all products for this Gene ID

UniProt

View information about Ly-6G on UniProt.org

Documentation

• Technical Data Sheet (pdf)
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

Other Formats

Certificate of Analysis